Literature DB >> 8858544

Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism.

A Heinz1, K Schmidt, S S Baum, S Kuhn, P Dufeu, L G Schmidt, H Rommelspacher.   

Abstract

OBJECTIVE: Dysfunction of dopaminergic transmission has been suggested as influencing withdrawal syndrome in alcohol-dependent patients. Therefore, dopamine levels and sensitivity of dopamine receptors were correlated with the severity of withdrawal syndrome in 40 alcoholics.
METHOD: Dopamine blood plasma levels and apomorphine-induced Growth Hormone (GH) release were measured on the first day of detoxification (Day 1) and after 8 days of abstinence (Day 8). Severity of withdrawal syndrome was assessed daily by the Clinical Institute Withdrawal Assessment (CIWA) score. In the 22 patients (out of the 40) treated by chlormethiazole, severity of withdrawal was measured by the required chlormethiazole dose.
RESULTS: A positive correlation was found between dopamine levels on Day 1 and the total CIWA score and necessary chlormethiazole dose, respectively. Correlation with the CIWA score was even stronger when the sensitivity of post-synaptic dopamine receptors was taken into account. No significant correlation between dopamine levels on Day 8 and withdrawal syndrome was found.
CONCLUSIONS: Our findings indicate an influence of dopaminergic transmission on withdrawal syndrome during early withdrawal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858544     DOI: 10.15288/jsa.1996.57.471

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  6 in total

1.  DBH*444G/A polymorphism of the dopamine-beta-hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms.

Authors:  M D Köhnke; W Kolb; A M Köhnke; U Lutz; S Schick; A Batra
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 2.  Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Authors:  Jing Liang; Richard W Olsen
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

3.  Decreased dopamine D(2) receptor function in cerebral cortex and brain stem: their role in hepatic ALDH regulation in ethanol treated rats.

Authors:  Akash K George; S Balarama Kaimal; C S Paulose
Journal:  Mol Cell Biochem       Date:  2007-05-26       Impact factor: 3.396

Review 4.  Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.

Authors:  Andrew J Muzyk; Suzanne Kerns; Scott Brudney; Jane P Gagliardi
Journal:  CNS Drugs       Date:  2013-11       Impact factor: 5.749

5.  Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence.

Authors:  Yunlong Ma; Rongli Fan; Ming D Li
Journal:  Alcohol Clin Exp Res       Date:  2016-05-24       Impact factor: 3.455

6.  Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU.

Authors:  Samuel G Rayner; Craig R Weinert; Helen Peng; Stacy Jepsen; Alain F Broccard
Journal:  Ann Intensive Care       Date:  2012-05-23       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.